Synopsis: Namita Thapar-backed Emcure Pharmaceuticals Ltd reported a resilient Q1FY26 performance, with net profit rising 9.1 percent QoQ and 40.5 percent YoY to Rs. 215 crore, aided by strong growth across both domestic and international markets. A pharma stock...
Two companies are in focus following significant trading activity today. This article examines substantial block and bulk deals observed in two prominent entities, highlighting the nature of these transactions and implications for the involved companies and market...
Shares of this small-cap pharma stock surged 1 percent on Wednesday after reputed brokerage firm Kotak Institutional Equities set a target price indicating potential upside. Share Price Variation In Wednesday’s trading session, the share price of Emcure...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
